Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer
- 18 December 2017
- journal article
- research article
- Published by Springer Nature in Surgery Today
- Vol. 48 (5) , 478-485
Abstract
The prognosis of most patients with stage IB node-negative gastric cancer is good without postoperative chemotherapy; however, about 10% suffer recurrence and inevitably die. We conducted this study to establish the optimal indications for postoperative adjuvant chemotherapy in patients at risk of recurrence.Keywords
This publication has 21 references indexed in Scilit:
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialThe Lancet Oncology, 2013
- High concordance between HercepTest immunohistochemistry and ERBB2 fluorescence in situ hybridization before and after implementation of American Society of Clinical Oncology/College of American Pathology 2007 guidelinesLaboratory Investigation, 2012
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registryGastric Cancer, 2012
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Trend in gastric cancer: 35 years of surgical experience in JapanWorld Journal of Gastroenterology, 2011
- A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer PatientsAnnals of Surgery, 2010
- Validation of staging systems for gastric cancerGastric Cancer, 2008
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord OvestJournal of Clinical Oncology, 2007
- Therapeutic strategy for patients with pN0 gastric carcinomaJournal of Surgical Oncology, 2006